Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone De Nitto

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical Chemistry and Laboratory Medicine|November 24, 2021
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boostersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|May 13, 2022
Three-month <i>ad interim</i> analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine boosterGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Diagnosis (Berlin, Germany)|January 19, 2023
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen testLaura Pighi, Brandon M Henry, Simone De Nitto, et al.
The Journal of Infection|July 2, 2021
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|June 23, 2021
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassayGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|March 8, 2023
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassayLaura Pighi, Brandon M Henry, Simone De Nitto, et al.
EJIFCC|August 23, 2021
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence ImmunoassayGian Luca Salvagno, Gianluca Gianfilippi, Giacomo Fiorio, et al.
Seminars in Thrombosis and Hemostasis|January 22, 2021
Thrombin Generation in Patients with Coronavirus Disease 2019Marco Benati, Gian Luca Salvagno, Simone De Nitto, et al.
Diagnostics (Basel, Switzerland)|August 5, 2020
Machine Learning Model Comparison in the Screening of Cholangiocarcinoma Using Plasma Bile Acids ProfilesDavide Negrini, Patrick Zecchin, Andrea Ruzzenente, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 VaccinationGian Luca Salvagno, Brandon M Henry, Giovanni di Piazza, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|November 24, 2021
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boostersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|May 13, 2022
Three-month <i>ad interim</i> analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine boosterGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Diagnosis (Berlin, Germany)|January 19, 2023
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen testLaura Pighi, Brandon M Henry, Simone De Nitto, et al.
The Journal of Infection|July 2, 2021
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workersGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|June 23, 2021
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassayGian Luca Salvagno, Brandon M Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine|March 8, 2023
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassayLaura Pighi, Brandon M Henry, Simone De Nitto, et al.
EJIFCC|August 23, 2021
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence ImmunoassayGian Luca Salvagno, Gianluca Gianfilippi, Giacomo Fiorio, et al.
Seminars in Thrombosis and Hemostasis|January 22, 2021
Thrombin Generation in Patients with Coronavirus Disease 2019Marco Benati, Gian Luca Salvagno, Simone De Nitto, et al.
Diagnostics (Basel, Switzerland)|August 5, 2020
Machine Learning Model Comparison in the Screening of Cholangiocarcinoma Using Plasma Bile Acids ProfilesDavide Negrini, Patrick Zecchin, Andrea Ruzzenente, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 VaccinationGian Luca Salvagno, Brandon M Henry, Giovanni di Piazza, et al.
Pageof 4